Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

12.03
-0.8500-6.60%
Post-market: 12.050.0200+0.17%19:59 EDT
Volume:757.60K
Turnover:9.10M
Market Cap:161.27M
PE:-0.83
High:12.78
Open:12.78
Low:11.60
Close:12.88
52wk High:69.97
52wk Low:11.60
Shares:13.41M
Float Shares:13.40M
Volume Ratio:1.51
T/O Rate:5.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.5713
EPS(LYR):-176.5980
ROE:-64.48%
ROA:-35.71%
PB:0.66
PE(LYR):-0.07

Loading ...

Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market to Nasdaq Global Select Market

THOMSON REUTERS
·
Mar 03

Tonix Pharmaceuticals - Received Approval From Nasdaq to Transfer Listing From Nasdaq Capital Market to the Nasdaq Global Select Market

THOMSON REUTERS
·
Mar 03

Tonix Pharmaceuticals Uplists to Nasdaq Global Select Market

Reuters
·
Mar 03

Alliance Global Partners Sticks to Their Buy Rating for Tonix Pharma (TNXP)

TIPRANKS
·
Mar 02

Tonix Pharmaceuticals Holding Corp. Publishes Investor Presentation on TONMYA Fibromyalgia Launch and Commercial Strategy

Reuters
·
Mar 01

Tonix Pharmaceuticals to Participate in TD Cowen Annual Healthcare Conference and Barclays Annual Healthcare Conference

Reuters
·
Feb 25

Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB), Integer Holdings (ITGR) and Tonix Pharma (TNXP)

TIPRANKS
·
Feb 23

Tonix Pharma (TNXP) Receives a Buy from Alliance Global Partners

TIPRANKS
·
Feb 17

Alliance Global Partners Sticks to Its Buy Rating for Tonix Pharma (TNXP)

TIPRANKS
·
Feb 09

Tonix Pharmaceuticals steigert die Investitionen im Gesamtjahr 2025 auf 3,4 Mio. USD, ein Anstieg um das 34-Fache

Reuters
·
Feb 03

BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology

Reuters
·
Jan 30

BUZZ-Tonix pain‑relief drug meets main goal in late‑stage study; shares fall

Reuters
·
Jan 30

Tonix Pharmaceuticals - Tonmya Reduces Pain Scores Significantly at Week 14

THOMSON REUTERS
·
Jan 30

Tonix Pharmaceuticals: Treatment Was Well Tolerated With Minimal Effects on Weight or Blood Pressure

THOMSON REUTERS
·
Jan 30

Tonix Pharmaceuticals: Tonmya Demonstrated Significant Reduction in Fibromyalgia Pain Compared With Placebo in Phase 3 Resilient Study

THOMSON REUTERS
·
Jan 30

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

GlobeNewswire
·
Jan 30

Tonix Pharmaceuticals Showcases Pipeline Progress and Fibromyalgia Drug Launch in Investor Presentation

Reuters
·
Jan 22

Tonix Pharmaceuticals Unveils Investor Presentation Highlighting FDA Approvals and Pipeline Advances

Reuters
·
Jan 10

Tonix Pharmaceuticals CEO to Present at Neuroscience Innovation Forum and Biotech Showcase

Reuters
·
Jan 06

Point72 Asset Management Lp Reports 9.2% Passive Stake in Tonix Pharmaceuticals as of Dec 29 - SEC Filing

THOMSON REUTERS
·
Jan 01